Inovio plans public offering of common stock
INO•Inovio Pharmaceuticals plans an underwritten public offering of common stock, with all shares to be sold by the company. Underwriters may buy additional shares equal to up to 15% of the offering under a 30-day option.
1. Offering details
Inovio Pharmaceuticals plans an underwritten public offering of common stock, with all shares to be sold by the company. The underwriters would have a 30-day option to purchase additional shares equal to up to 15% of the offering; Jefferies and Piper Sandler are joint book-running managers.
